Cargando…

Enhancing the antibacterial activity of antimicrobial peptide PMAP-37(F34-R) by cholesterol modification

BACKGROUND: The problem of increasing resistance against conventional antibiotics has drawn people’s attention. Therefore, the development of novel antibacterial agents with effective and safe therapeutic effects is imminent. Antimicrobial peptides (AMPs) are considered a promising class of antibact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Liangliang, Shen, Tengfei, Liu, Yongqing, Zhou, Jiangfei, Shi, Shuaibing, Wang, Yang, Zhao, Zhanqin, Yan, Zhiling, Liao, Chengshui, Wang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607875/ https://www.ncbi.nlm.nih.gov/pubmed/33138816 http://dx.doi.org/10.1186/s12917-020-02630-x

Ejemplares similares

N-terminal Myristoylation Enhanced the Antimicrobial Activity of Antimicrobial Peptide PMAP-36PW
por: Liu, Yongqing, et al.
Publicado: (2020)

Porcine Myeloid Antimicrobial Peptides: A Review of the Activity and Latest Advances
por: Shi, Shuaibing, et al.
Publicado: (2021)

Antibacterial peptide PMAP-37(F34-R), expressed in Pichia pastoris, is effective against pathogenic bacteria and preserves plums
por: Dong, Chunming, et al.
Publicado: (2023)

Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement
por: Liu, Yongqing, et al.
Publicado: (2021)

Sustained release of alginate hydrogel containing antimicrobial peptide Chol-37(F34-R) in vitro and its effect on wound healing in murine model of Pseudomonas aeruginosa infection
por: Shi, Shuaibing, et al.
Publicado: (2023)

Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action
por: Scheenstra, Maaike R., et al.
Publicado: (2019)

Synergistic Antimicrobial Effect of Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 With Erythromycin Against Bacterial Pathogens
por: Lu, Yi, et al.
Publicado: (2022)

Comparison of immunoadjuvant activities of four bursal peptides combined with H9N2 avian influenza virus vaccine
por: Zhang, Cong, et al.
Publicado: (2018)

PMAP: databases for analyzing proteolytic events and pathways
por: Igarashi, Yoshinobu, et al.
Publicado: (2009)

Antimicrobial Properties and Membrane-Active Mechanism of a Potential α-Helical Antimicrobial Derived from Cathelicidin PMAP-36
por: Lv, Yinfeng, et al.
Publicado: (2014)

Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida
por: Lyu, Yinfeng, et al.
Publicado: (2016)

Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36
por: Biondi, Barbara, et al.
Publicado: (2023)

High-Quality Nucleic Acid Isolation from Hard-to-Lyse Bacterial Strains Using PMAP-36, a Broad-Spectrum Antimicrobial Peptide
por: Cho, Hye-sun, et al.
Publicado: (2021)

The Central PXXP Motif Is Crucial for PMAP-23 Translocation across the Lipid Bilayer
por: Yang, Sung-Tae, et al.
Publicado: (2021)

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
por: Zhuo, Haiwei, et al.
Publicado: (2022)

Enhanced Expression and Functional Characterization of the Recombinant Putative Lysozyme-PMAP36 Fusion Protein
por: Rao, Zhili, et al.
Publicado: (2019)

PMAP-36 reduces the innate immune response induced by Bordetella bronchiseptica-derived outer membrane vesicles
por: Balhuizen, Melanie D., et al.
Publicado: (2020)

2-PMAP Ameliorates Cerebral Vasospasm and Brain Injury after Subarachnoid Hemorrhage by Regulating Neuro-Inflammation in Rats
por: Wu, Chieh-Hsin, et al.
Publicado: (2022)

Evaluation of the T-SPOT.TB test, oxidation-related factors, and antimicrobial peptide LL-37 in the diagnosis of pulmonary tuberculosis with type 2 diabetes
por: Ma, Liangliang, et al.
Publicado: (2021)

Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus
por: Meguro, Shu, et al.
Publicado: (2014)

Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models
por: KWON, Ae Jeong, et al.
Publicado: (2016)

“Superwobbling” and tRNA-34 Wobble and tRNA-37 Anticodon Loop Modifications in Evolution and Devolution of the Genetic Code
por: Lei, Lei, et al.
Publicado: (2022)

Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
por: Lu, Fatai, et al.
Publicado: (2022)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
por: Tao, Rui, et al.
Publicado: (2023)

Experimental evidence for particle stability of ${34}^Ne$ and ${37}^Na$
por: Lukyanov, S M, et al.
Publicado: (2002)

Single-neutron knockout from $^{34,35}$Si and $^{37}$S
por: Enders, J, et al.
Publicado: (2001)

Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate
por: Wei, Jiantong, et al.
Publicado: (2021)

Cholesterols Work as a Molecular Regulator of the Antimicrobial Peptide-Membrane Interactions
por: Li, Jia, et al.
Publicado: (2021)

OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
por: Lin, Ming-Feng, et al.
Publicado: (2015)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

The Contribution of Antimicrobial Peptides to Immune Cell Function: A Review of Recent Advances
por: Li, Hanxiao, et al.
Publicado: (2023)

Antibacterial Peptide BSN-37 Kills Extra- and Intra-Cellular Salmonella enterica Serovar Typhimurium by a Nonlytic Mode of Action
por: Yang, Lei, et al.
Publicado: (2020)

Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1
por: Wang, Wei, et al.
Publicado: (2017)

PmAP2-β depletion enhanced activation of the Toll signaling pathway during yellow head virus infection in the black tiger shrimp Penaeus monodon
por: Jatuyosporn, Thapanan, et al.
Publicado: (2021)

Antibacterial and osteogenesis performances of LL37-loaded titania nanopores in vitro and in vivo
por: Shen, Xinkun, et al.
Publicado: (2019)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bb8sfv7ci74rr49kfcjrii89e4